文献速递药疹与重症皮肤不良反应

甲氨蝶呤诱导的表皮坏死:24例病例系列

Methotrexate-induced epidermal necrosis: A case series of 24 patients.
PubMed 文献 · J Am Acad Dermatol · 2017-05-10

该研究纳入24例甲氨蝶呤诱导的表皮坏死(MEN)患者和150例对照,分析临床病理、危险因素及预后因素。MEN表现为广泛皮肤坏死(平均33.2%体表面积)但无靶形损害,组织病理示角质形成细胞营养不良;79.2%接受亚叶酸钙治疗,死亡率仍达16.7%。危险因素包括年龄>60岁、慢性肾病及高初始剂量甲氨蝶呤未补充叶酸。

要点

  • MEN早期征象包括疼痛性皮肤糜烂、口腔溃疡和白细胞/血小板减少。
  • 高龄、慢性肾病及高初始剂量甲氨蝶呤未补叶酸是MEN危险因素。
  • 严重肾病和白细胞减少预测MEN不良预后,SCORe of TEN标准与死亡率无关。

核心结论

  • MEN具有与SJS/TEN不同的临床病理特征,识别早期征象和预后因素重要,因快速给予亚叶酸钙可能有帮助。
  • 为降低MEN风险,医生应避免给高危患者处方甲氨蝶呤,并缓慢上调剂量同时补充叶酸。

研究设计与样本

  • 研究纳入24例MEN患者和150例对照,分析人口学、病理及甲氨蝶呤血浆浓度。

主要发现

  • MEN患者显示广泛皮肤坏死(平均33.2%体表面积)但无靶形损害。
  • 组织病理显示角质形成细胞营养不良。
  • 早期征象包括疼痛性皮肤糜烂、口腔溃疡和白细胞减少/血小板减少。
  • 79.2%患者接受亚叶酸钙治疗,死亡率16.7%。
  • 肾功能不全会延迟甲氨蝶呤清除。

关键数值与推荐

  • MEN危险因素包括年龄>60岁、慢性肾病和高初始剂量甲氨蝶呤未补充叶酸。
  • 严重肾病和白细胞减少预测MEN不良预后。
  • SCORe of Toxic Epidermal Necrosis标准均与MEN死亡率无关。

临床怎么用

  • 识别MEN早期征象(疼痛性皮肤糜烂、口腔溃疡、血细胞减少)以快速给予亚叶酸钙。
  • 避免给高龄、慢性肾病等高危患者处方甲氨蝶呤,必要时缓慢上调剂量并补充叶酸。

局限性

  • 研究受限于样本量小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Methotrexate-induced epidermal necrosis (MEN) is a rare but life-threatening cutaneous reaction that mimics Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). OBJECTIVES: To investigate the clinicopathology, risk factors, and prognostic factors of MEN. METHODS: We enrolled 24 patients with MEN and 150 controls and analyzed the demographics, pathology, and plasma concentrations of methotrexate (MTX). RESULTS: Patients with MEN showed extensive skin necrosis (mean, 33.2% total body surface area) but no target lesions. The histopathology displayed keratinocyte dystrophy. Early signs of MEN included painful skin erosions, oral ulcers, and leukopenia/thrombocytopenia. Although 79.2% patients received leucovorin treatment, there was 16.7% mortality. Risk factors for MEN included older age (>60 years), chronic kidney disease, and high initial dosage of MTX without folic acid supplementation. Renal insufficiency delayed MTX clearance. Severe renal disease and leukopenia predicted poor prognosis in MEN, but none of the SCORe of Toxic Epidermal Necrosis criteria were associated with mortality of MEN. LIMITATIONS: The study was limited by the small sample size. CONCLUSION: MEN exhibited distinct clinicopathologic features from SJS/TEN. Recognition of the early signs and prognostic factors is important, because the rapid institution of leucovorin may be helpful. To reduce the risk of MEN, physicians should avoid prescribing MTX to high-risk patients and titrate the dosage slowly upward with folic acid supplementation.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Chen TJ, Chung WH, Chen CB, et al. Methotrexate-induced epidermal necrosis: A case series of 24 patients. J Am Acad Dermatol. 2017. PMID: 28499754. doi:10.1016/j.jaad.2017.02.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。